InvestorsHub Logo

DaubersUP

01/24/18 2:53 PM

#214032 RE: DaubersUP #214031

That would warrant TOP DOG in Oral psoriasis. Meaning ATLEAST 2 billion a year once on market

Meaning a 60 dollar plus share price

cabel

01/24/18 2:56 PM

#214033 RE: DaubersUP #214031

With all due respect I will place my dart at:

PASI 75 at 47% is my dart,... in February!

To infinity and beyond!

01/24/18 6:06 PM

#214048 RE: DaubersUP #214031

I hope you are right

I will guess that the result will be small if any benefit, and that will be the end of prurisol for psorioasis. It would be great if this were not the case

P2a too small to predict anything, really, despite what the company has said so far

sox040713

01/24/18 9:05 PM

#214073 RE: DaubersUP #214031

My dart is at least 50% PASI 75 in early March.

New Information: Greatest Efficacy Seen in Patients with Moderate Psoriasis

Among patients participating in the study with the severest form of psoriasis, those having a baseline IGA score of 3 (“moderate”), the primary endpoint was met in 46.2% of patients who received Prurisol 200mg. This data was derived from analyses of all patients randomized across all 9 participating study sites.



http://www.ipharminc.com/press-release/2016/11/12/cellceutix-provides-additional-insight-into-successful-phase-2-trial-for-treating-psoriasis